Maternal GDM Tied to Child's Cardiometabolic Profile

Share this content:
Maternal GDM Tied to Child's Cardiometabolic Profile
Maternal GDM Tied to Child's Cardiometabolic Profile

WEDNESDAY, Nov. 22, 2017 (HealthDay News) -- Teenage offspring of mothers with gestational diabetes mellitus (GDM) have increased adiposity and an adverse cardiometabolic profile, according to a study published online Oct. 16 in Diabetes Care.

Louise G. Grunnet, Ph.D., from Rigshospitalet in Copenhagen, Denmark, and colleagues compared body composition and associated cardiometabolic traits among 561 9- to 16-year-old offspring of mothers with GDM and 597 control offspring.

The researchers found that offspring of mothers with GDM exhibited higher weight, body mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure, and resting heart rate, and lower height, after adjustment for age and sex. Higher total and abdominal fat percentages and lower muscle mass percentages were seen for offspring of mothers with GDM; after correction for offspring BMI, these differences disappeared. Higher fasting plasma glucose, insulin, C-peptide, homeostatic model assessment of insulin resistance (HOMA-IR), and plasma triglyceride levels were seen for offspring of mothers with GDM; they also had reduced fasting plasma high-density lipoprotein cholesterol levels. Compared with control offspring, female offspring of mothers with GDM had earlier onset of puberty. After adjustment for maternal prepregnancy BMI, offspring of mothers with GDM had significantly higher BMI, WHR, fasting glucose, and HOMA-IR; glucose and HOMA-IR remained elevated after correction for maternal and offspring BMI.

"Adolescent offspring of women with GDM show increased adiposity, an adverse cardiometabolic profile, and earlier onset of puberty among girls," the authors write.

One author disclosed financial ties to Novo Nordisk.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab + Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »